
In this free webinar, learn how different clinical research site models can affect feasibility, patient access and study execution. The featured speakers will discuss how sponsors can balance site relationships, performance, capabilities and patient access when selecting sites, including the role of decentralized trial approaches. Attendees will also explore how stronger sponsor-CRO-site alignment and more flexible execution models can support trial performance and patient experience.
TORONTO, Sept. 17, 2026 /PRNewswire/ -- As the investigative site landscape becomes increasingly segmented, are traditional approaches to site selection and study execution still delivering the best results? Growing operational complexity, changing ownership models, new technologies and increasing expectations for patient-centric trials are creating meaningful differences among academic medical center-affiliated sites, independent community-based sites and larger site networks, with important implications for patient access and trial performance.
Drawing on insights from the Tufts Center for the Study of Drug Development (Tufts CSDD) global research study, "Mapping and Assessing the Global Investigative Site Landscape: Different Site Execution Models," this fireside discussion brings together perspectives spanning research, biotech, a site network and a CRO to examine the evolving investigative site landscape and what it means for clinical trial strategy and execution.
Panelists will explore how sponsors can balance therapeutic expertise, demonstrated performance, infrastructure, patient access and established relationships when selecting sites, and whether reliance on familiar partners may limit opportunities to identify emerging high-performing sites and alternative execution models.
The conversation will also address patient access and decentralized clinical trial approaches, including whether new technologies are truly reducing participation barriers or simply shifting operational burden to sites. The featured speakers will consider how sponsors, CROs and sites can maintain accountability for the patient experience while adapting execution models to different site capabilities.
Finally, speakers will explore the role of data-driven site selection, communication, financial sustainability and cross-industry collaboration in building more flexible study strategies that improve trial performance while supporting sites and patients.
Register for this webinar to learn how patient access can be strengthened through more effective site selection, decentralized trial approaches and flexible clinical trial execution models.
Join Joan A. Chambers, Senior Consultant, Tufts Center for the Study of Drug Development; Phill Gallacher, Senior Vice President, Head of Clinical Operations & Program Management, Cullinan Therapeutics, Inc.; Chloe Rose, PhD, Vice President, Site Solutions & Portfolio Management, Pratia; and Almenia Garvey, MSc, Executive Director, Global Feasibility, Site & Patient Engagement, Allucent, for the live webinar on Thursday, October 8, 2026, at 11am EDT (5pm CEST / EU-Central).
For more information, or to register for this event, visit The Landscape of Clinical Research Sites & Novel Executional Models.
ABOUT XTALKS
Xtalks – The Life Science Community™ empowers professionals across pharma, biotech, medtech, healthcare and research with the trusted knowledge and collaborative insights that move the industry forward. Powered by Honeycomb Worldwide Inc., Xtalks delivers news, feature articles, webinars, podcasts, videos, expert interviews, curated job opportunities and more designed to support informed decision-making in a fast-evolving sector.
Every year, thousands of professionals rely on Xtalks for timely intelligence, peer perspectives and industry thought leadership. Join our life science community to stay informed, connected and ready for what's next.
To learn more about Xtalks, visit www.xtalks.com
For information about working with Xtalks to host your webinar, visit https://xtalks.com/partner-with-us/
Contact:
Soumya Shashikumar
Tel: +1 (416) 977-6555 x371
Email: [email protected]
SOURCE Xtalks
Share this article